Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

AMEGA: antigen-mediated genetically modified cell amplification.

Masahiro Kawahara1, Hiroshi Ueda, Kouhei Tsumoto

  • 1Department of Chemistry and Biotechnology, Graduate School of Engineering, The University of Tokyo, Hongo, Bunkyo, Tokyo 113-8656, Japan. kawahara@bio.t.u-tokyo.ac.jp

Journal of Immunological Methods
|January 23, 2004
PubMed
Summary

This study introduces antigen-mediated genetically modified cell amplification (AMEGA), a novel positive selection method. AMEGA enables efficient isolation of genetically modified cells using chimeric receptors, avoiding cytotoxic drugs and improving cell engineering outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-Vesicular Release of Alarmin Prothymosin α Complex Associated with Annexin-2 Flop-Out.

Cells·2023
Same author

Development of green fluorescent protein-based cAMP indicators for covering a wide range of cAMP concentrations.

RSC advances·2023
Same author

A Real-Time Learning Analytics Dashboard for Automatic Detection of Online Learners' Affective States.

Sensors (Basel, Switzerland)·2023
Same author

Formation of Hemihydrate Crystal form Overcomes Milling Issue Induced by Exposed Functional Groups on Cleavage Plane for a Y5 Receptor Antagonist of Neuropeptide Y.

Journal of pharmaceutical sciences·2023
Same author

Efficient Microfluidic Screening Method Using a Fluorescent Immunosensor for Recombinant Protein Secretions.

Small (Weinheim an der Bergstrasse, Germany)·2023
Same author

Generation of Q-bead against bone Gla protein with simplified preparation steps.

Journal of immunological methods·2023

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biotechnology

Background:

  • Antibiotic selection for genetically modified cells can harm both target and non-target cells.
  • Cytotoxic drugs used in selection can have deleterious effects on engineered cells.
  • There is a need for positive selection methods that promote the growth of desired cells.

Purpose of the Study:

  • To develop a positive screening method for genetically modified cells.
  • To engineer cells using a novel antigen-based selection system.
  • To overcome limitations associated with traditional antibiotic-based cell selection.

Main Methods:

  • Constructed chimeric receptors by fusing antibody V(H) or V(L) regions with erythropoietin receptor (EpoR) or gp130 domains.
  • Co-infected Ba/F3 cells with retroviruses encoding a model transgene (EGFP) and chimeric receptors.

Related Experiment Videos

  • Applied direct antigen (hen egg lysozyme - HEL) selection in the absence of interleukin-3 (IL-3) to isolate modified cells.

    • Main Results:

    • Achieved a single population of EGFP-positive cells after one round of selection.
    • Demonstrated successful antigen-mediated genetically modified cell amplification (AMEGA).
    • Validated the efficacy of the chimeric receptor system for positive cell selection.

    Conclusions:

    • AMEGA provides an efficient positive selection strategy for genetically modified cells.
    • This method avoids cytotoxic drug administration, preserving cell viability.
    • AMEGA facilitates the engineering of cells with desired properties through targeted growth induction.